Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro
- PMID: 7601429
Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro
Abstract
Hepatitis B virus (HBV) DNA-transfected hepatoma cells were incubated with the immunosuppressive agents prednisolone, azathioprine, and cyclosporin A (CsA) and the antiviral agents ganciclovir and foscarnet to investigate the effects of these compounds on HBV replication. Prednisolone and azathioprine increased intracellular viral DNA and RNA levels approximately twofold and fourfold, respectively. Treatment with CsA did not alter the levels of viral RNA or DNA. A combination of all three immunosuppressive agents increased the level of intracellular viral DNA eightfold, indicating an additive effect. Incubation of the cells in the presence of foscarnet decreased levels of both single-stranded and relaxed circular viral DNA, and in the presence of ganciclovir decreased the levels of relaxed circular viral DNA, predictable effects from their known mechanism of action. The stimulatory effect on viral replication induced by the combination of immunosuppressive agents was substantially inhibited by ganciclovir-foscarnet treatment. These observations could have implications for the management of recurrent HBV infection after liver transplantation.
Similar articles
-
Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.J Ethnopharmacol. 2009 Jul 15;124(2):189-96. doi: 10.1016/j.jep.2009.04.046. Epub 2009 May 3. J Ethnopharmacol. 2009. PMID: 19409970
-
[An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].Zhonghua Gan Zang Bing Za Zhi. 2002 Aug;10(4):275-8. Zhonghua Gan Zang Bing Za Zhi. 2002. PMID: 12223138 Chinese.
-
Silver nanoparticles inhibit hepatitis B virus replication.Antivir Ther. 2008;13(2):253-62. Antivir Ther. 2008. PMID: 18505176
-
Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.Antivir Ther. 2007;12 Suppl 3:H15-23. Antivir Ther. 2007. PMID: 18284179 Review.
-
Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.Antivir Chem Chemother. 2001;12 Suppl 1:131-42. Antivir Chem Chemother. 2001. PMID: 11594680 Review.
Cited by
-
Prophylaxis of hepatitis B infection in solid organ transplant recipients.Therap Adv Gastroenterol. 2013 Jul;6(4):309-19. doi: 10.1177/1756283X13487942. Therap Adv Gastroenterol. 2013. PMID: 23814610 Free PMC article.
-
Role of nucleoside/nucleotide analogues and low-dose hepatitis B immune globülin in prophylaxis of hepatitis B recurrence among cadaveric liver transplant recipients.Turk J Gastroenterol. 2018 Jan;29(1):61-66. doi: 10.5152/tjg.2018.17595. Turk J Gastroenterol. 2018. PMID: 29391309 Free PMC article.
-
Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?J Clin Transl Hepatol. 2014 Dec;2(4):259-65. doi: 10.14218/JCTH.2014.00023. Epub 2014 Dec 15. J Clin Transl Hepatol. 2014. PMID: 26356785 Free PMC article. Review.
-
Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation.Gastroenterol Hepatol (N Y). 2014 Mar;10(3):175-9. Gastroenterol Hepatol (N Y). 2014. PMID: 24829544 Free PMC article.
-
Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.Clin Gastroenterol Hepatol. 2009 Oct;7(10):1130-7. doi: 10.1016/j.cgh.2009.06.027. Epub 2009 Jul 1. Clin Gastroenterol Hepatol. 2009. PMID: 19577007 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources